CoChat

Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey

Open access
Gaolathe, Tendani, Wirth, Kathleen E, Holme, Molly Pretorius, Makhema, Joseph, Moyo, Sikhulile, Chakalisa, Unoda, Yankinda, Etienne Kadima, Lei, Quanhong, Mmalane, Mompati, Novitsky, Vlad, Okui, Lillian, van Widenfelt, Erik, Powis, Kathleen M, Khan, Nealia, Bennett, Kara, Bussmann, Hermann, Dryden-Peterson, Scott, Lebelonyane, Refeletswe, el-Halabi, Shenaaz, Mills, Lisa A, Marukutira, Tafireyi, Wang, Rui, Tchetgen, Eric J Tchetgen, DeGruttola, Victor, Essex, M, Lockman, Shahin · 2016 · The Lancet HIV
Cited by 228

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary Background Global HIV programs continue to experience challenges achieving the high rates of HIV testing and treatment needed to optimize health and reduce transmission. Botswana represents a useful “demonstration case” in assessing the feasibility of achieving the new UNAIDS targets for 2020: 90% of all persons living with HIV knowing their status, 90% of these individuals receiving sustained antiretroviral treatment (ART), and 90% of those on ART having virologic suppression (“90–90–90”). Methods A population-based random sample of individuals was recruited and interviewed in 30 rural and peri-urban communities from October 2013 to November 2015 in Botswana as part of a large, ongoing PEPFAR-funded community-randomized trial designed to evaluate the impact of a combination prevention package on HIV incidence. A random sample of approximately 20% of households in each of these 30 communities was selected. Consenting household residents aged 16–64 years who were Botswana citizens or spouses of citizens responded to a questionnaire and had blood drawn for HIV testing in absence of documentation of positive HIV status. HIV-1 RNA testing was performed in all HIV-infected participants, regardless of treatment status. Findings Eighty-one percent of enumerated eligible household members took part in the survey (10% refused and 9% were absent). Among 12,610 participants surveyed, 3,596 (29%) were HIV infected; 2,995 (83·3%) of these individuals already knew their HIV status. Among those who knew their HIV status, 2,617 (87·4%) were currently receiving ART (this represented 95% of those eligible for ART by current Botswana national guidelines, and 73% of all HIV-infected persons). We obtained an HIV-1 RNA result in 99·7% of HIV-infected participants. Of the 2,609 individuals currently receiving ART with a viral load measurement, 2,517 (96·5%) had HIV-1 RNA ≤400 copies/mL. Overall, 70·2% of HIV-infected persons had virologic suppression, close to the UNAIDS target of 73%. Results of three sensitivity analyses to account for possible uncertainty due to non-participation and under-representation of urban areas, revealed somewhat lower, but nevertheless remarkably high 90–90–90 coverage. Interpretation Botswana, a resource-constrained setting with high HIV prevalence, appears to have achieved very high rates of HIV testing, treatment coverage, and virologic suppression for those on ART in this population-based survey, despite the Botswana ART initiation threshold of ≤350 cells/mm3. These findings provide evidence that the UNAIDS 90-90-90 targets, while ambitious, are achievable even in resource-constrained settings with high HIV burden. Funding The United States President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2352-3018(16)00037-0

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 228

Metadata

Authors
Gaolathe, T., Wirth, K. E., Holme, M. P., Makhema, J., Moyo, S., Chakalisa, U., Yankinda, E. K., Lei, Q., Mmalane, M., Novitsky, V., Okui, L., van Widenfelt, E., Powis, K. M., Khan, N., Bennett, K., Bussmann, H., Dryden-Peterson, S., Lebelonyane, R., el-Halabi, S., Mills, L. A., Marukutira, T., Wang, R., Tchetgen, E. J. T., DeGruttola, V., Essex, M., & Lockman, S.
Venue
The Lancet HIV
Publisher
Elsevier BV
Published
2016-05
Volume
3
Issue
5
Pages
e221-e230
ISSN
2352-3018 (ISSN-L)
OpenAlex
W2310218779
Cited by
228
References
3
FWCI
27.72
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. https://app.cochat.ai/papers/10.1016/s2352-3018(16)00037-0
The paper
Gaolathe, T., Wirth, K. E., Holme, M. P., Makhema, J., Moyo, S., Chakalisa, U., Yankinda, E. K., Lei, Q., Mmalane, M., Novitsky, V., Okui, L., van Widenfelt, E., Powis, K. M., Khan, N., Bennett, K., Bussmann, H., Dryden-Peterson, S., Lebelonyane, R., el-Halabi, S., . . . Lockman, S. (2016). Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based survey. The Lancet HIV. https://doi.org/10.1016/s2352-3018(16)00037-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.